EPIMOGRIFY Trademark

Trademark Overview


On Tuesday, March 22, 2022, a trademark application was filed for EPIMOGRIFY with the United States Patent and Trademark Office. The USPTO has given the EPIMOGRIFY trademark a serial number of 79347429. The federal status of this trademark filing is REGISTERED as of Tuesday, February 6, 2024. This trademark is owned by Mogrify Limited. The EPIMOGRIFY trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Treatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs; custom manufacture of transcription factors, ligands, cell surface receptors, cells, cell therapies and gene therapies; information, advisory and consultancy services in relation to all of the aforesaid services

Downloadable bioinformatics software for epigenomic data analysis; downloadable computer software platforms for epigenomic data analysis in the field of cell and gene therapies; downloadable bioinformatics computer software platforms for epigenomic data analysis in the field of cell and gene therapies; scientific apparatus for measuring and analysing scientific study data, namely, apparatus for recording, transmission or reproduction of data, video, audio, images and text; data analysis apparatus,namely, data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software

Medical and veterinary preparations for therapeutic purposes, namely pharmaceutical, biopharmaceutical and veterinary preparations for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; pharmaceutical and biopharmaceutical preparations for cell and gene therapy; biological preparations for modifying human or animal cells for medical or therapeutic purposes, namely, transcription factors, ligands and cell surface receptors for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; biological, chemical and biochemical reagents for medical use; cells for medical or clinical use; vaccines

Reagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for scientific and research use; chemical substances, namely transcription factors and ligands for scientific and industrial use; cells for scientific and research use

Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; cell and gene therapy services, namely, manipulation of human and animal cells for therapeutic purposes; medical services, namely, reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies

Scientific and technological services namely research and design analysis in the field of cell and gene therapies; industrial research services in the field of cell and gene therapies; medical and veterinary research services namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy and gene therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; medical laboratory services; medical research laboratory services, in the field of cell and gene therapies; software as a service (SaaS) services featuring software for use in epigenomic data analysis; platform as a service (Paas) services featuring a bioinformatics software platform for use in manufacturing therapeutics; providing an online non-downloadable bioinformatics software ...
epimogrify

General Information


Serial Number79347429
Word MarkEPIMOGRIFY
Filing DateTuesday, March 22, 2022
Status700 - REGISTERED
Status DateTuesday, February 6, 2024
Registration Number7295995
Registration DateTuesday, February 6, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2023

Trademark Statements


Goods and ServicesTreatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs; custom manufacture of transcription factors, ligands, cell surface receptors, cells, cell therapies and gene therapies; information, advisory and consultancy services in relation to all of the aforesaid services
Goods and ServicesDownloadable bioinformatics software for epigenomic data analysis; downloadable computer software platforms for epigenomic data analysis in the field of cell and gene therapies; downloadable bioinformatics computer software platforms for epigenomic data analysis in the field of cell and gene therapies; scientific apparatus for measuring and analysing scientific study data, namely, apparatus for recording, transmission or reproduction of data, video, audio, images and text; data analysis apparatus,namely, data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software
Goods and ServicesMedical and veterinary preparations for therapeutic purposes, namely pharmaceutical, biopharmaceutical and veterinary preparations for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; pharmaceutical and biopharmaceutical preparations for cell and gene therapy; biological preparations for modifying human or animal cells for medical or therapeutic purposes, namely, transcription factors, ligands and cell surface receptors for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; biological, chemical and biochemical reagents for medical use; cells for medical or clinical use; vaccines
Goods and ServicesReagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for scientific and research use; chemical substances, namely transcription factors and ligands for scientific and industrial use; cells for scientific and research use
Goods and ServicesMedical services; veterinary services; medical services for the treatment of conditions of the human or animal body; cell and gene therapy services, namely, manipulation of human and animal cells for therapeutic purposes; medical services, namely, reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies
Goods and ServicesScientific and technological services namely research and design analysis in the field of cell and gene therapies; industrial research services in the field of cell and gene therapies; medical and veterinary research services namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy and gene therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; medical laboratory services; medical research laboratory services, in the field of cell and gene therapies; software as a service (SaaS) services featuring software for use in epigenomic data analysis; platform as a service (Paas) services featuring a bioinformatics software platform for use in manufacturing therapeutics; providing an online non-downloadable bioinformatics software platform for identifying transcription factors, ligands and cell surface receptors to turn one cell type into another cell type; providing an online non-downloadable bioinformatics platform for identifying transcription factors, ligands and cell surface receptors to maintain cell conversion; advisory and consultancy relating to all the aforesaid services

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMogrify Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameMogrify Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameMogrify Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, August 18, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 23, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Tuesday, January 17, 2023NON-FINAL ACTION WRITTEN
Wednesday, January 18, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 10, 2023REFUSAL PROCESSED BY MPU
Friday, March 10, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 6, 2023REFUSAL PROCESSED BY IB
Thursday, September 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 16, 2023FINAL REFUSAL WRITTEN
Monday, October 16, 2023FINAL REFUSAL E-MAILED
Monday, October 16, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 18, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 18, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, October 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 18, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, October 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 1, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTIFICATION PROCESSED BY IB
Tuesday, November 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 24, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, May 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 9, 2024FINAL DISPOSITION NOTICE SENT TO IB
Sunday, June 2, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 9, 2024FINAL DISPOSITION PROCESSED
Tuesday, February 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB